GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,467.50p
   
  • Change Today:
    -21.00p
  • 52 Week High: 1,812.50p
  • 52 Week Low: 1,293.50p
  • Currency: UK Pounds
  • Shares Issued: 4,129.58m
  • Volume: 1,393,339
  • Market Cap: £60,602m
  • RiskGrade: 129
  • Beta: 0.01
Select chart: 1 week
 

Current

1 week

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 32,881.25 9,284.85 169.53p 8.8 1.4 +6% 65.12p 0.0%
31-Dec-26 34,550.79 10,164.82 187.40p 7.9 0.7 +10% 69.67p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
31-Dec-2025 32,881 32,820 n/a n/a n/a n/a
31-Dec-2026 34,551 34,551 n/a n/a n/a n/a
31-Dec-2027 35,952 35,952 n/a n/a n/a n/a
 
Earnings
31-Dec-2025 169.53p 168.88p n/a n/a n/a n/a
31-Dec-2026 187.40p 187.40p n/a n/a n/a n/a
31-Dec-2027 201.89p 201.89p n/a n/a n/a n/a
 
Dividend
31-Dec-2025 65.12p 65.12p n/a n/a n/a n/a
31-Dec-2026 69.67p 69.67p n/a n/a n/a n/a
31-Dec-2027 73.47p 73.47p n/a n/a n/a n/a
 
Recommendations
Strong Buy 4 4 0 0 0 0
Buy 3 2 0 0 0 0
Neutral 15 16 0 0 0 0
Sell 3 3 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 25 25 0 0 0 0
 
Average Rec 5.80 5.70 n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

GSK Market Data

Currency UK Pounds
Share Price 1,467.50p
Change Today -21.00p
% Change -1.41 %
52 Week High 1,812.50p
52 Week Low 1,293.50p
Volume 1,393,339
Shares Issued 4,129.58m
Market Cap £60,602m
Beta 0.01
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average66.97% below the market average
14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average14.89% below the sector average
Price Trend
2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average2.97% above the market average
30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average30.61% above the sector average
Income
62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average62.82% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average47.2% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 15
Sell 3
Strong Sell 0
Total 25
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 20-Feb-25 14-Nov-24
Paid 10-Apr-25 09-Jan-25
Amount 16.00p 15.00p

Trades for 31-Mar-2025

Time Volume / Share Price
12:13 1 @ 1,468.00p
12:13 436 @ 1,467.50p
12:12 608 @ 1,467.50p
12:12 649 @ 1,467.50p
12:12 200 @ 1,467.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page